Does night work put women's health at risk?

June 19, 2012 in Cancer

Breast cancer is the number one cause of female mortality. It affects 100 out of 100,000 women per year in developed countries. Each year, more than 1.3 million new cases are diagnosed, 53,000 of these in France.

The risk factors of breast cancer are varied. They include , late first pregnancy, low parity or hormone therapy, but other causes of breast cancer such as way of life, environmental or professional causes have not yet been completely identified.

In 2010, based on experimental and epidemiological work, the International Agency for Research on Cancer (IARC) classified work that disturbed the circadian rhythm as being "probably carcinogenic". The circadian rhythm, that regulates the alternation between and sleep, controls numerous biological functions and is altered in people who work at night or who have disrupted working hours. Several hypotheses have been put forward to explain the observed links between night work and breast cancer: exposure to light during the night, that eliminates the nocturnal melatonin surge and its anti-carcinogenic effects, disturbed functioning of the biological that control cell proliferation, or that can weaken the immune system.

So the Inserm researchers examined the effect of night work on the health of women in a major population study carried out in France between 2005 and 2008. The careers of 3000 women were examined, including each period of night work. In total, over 11% of women had worked nights at some time during their career.

The risk of developing breast cancer was 30% higher in women who had worked nights compared to women who had never worked nights. This increased risk was particularly marked in women who had worked nights for over four years, or in women whose working rhythm was less than 3 nights per week, because this led to more frequent disturbances between night and day rhythms.

Finally, the link between night work and seemed to be more marked when we looked at women who had worked at night prior to a first pregnancy. An explanation for this result could be that the mammary cells, incompletely differentiated in women before their first pregnancy, are more vulnerable.

"Our work has corroborated the results of previous studies and poses the problem of taking night work into consideration in public health management, especially since the number of women working atypical hours is on the increase", states Pascal Guénel, the main author of this work.

More information: Night work and breast cancer: a population-based case-control study in France (the CECILE study) , International Journal of Cancer, onlinelibrary.wile… 669/abstract

Journal reference: International Journal of Cancer search and more info website

Provided by Institut National de la Sante et de la Recherche Medicale search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Racial disparities in the surgical management of non-small cell lung cancer

The surgical management of non-small cell lung cancer (NSCLC) in U.S. hospitals varies widely depending on the race of the patient, according to a new study.

Cancer created 2 hours ago | popularity not rated yet | comments 0

Treatment with A1-PI slows the progression of emphysema in Alpha-1 antitrypsin deficiency

Treatment with an Alpha-1 proteinase inhibitor (A1-PI), a naturally occurring protein that protects lung tissue from breakdown and protects the lung's elasticity, is effective in slowing the progression of emphysema in patients ...

Cancer created 2 hours ago | popularity not rated yet | comments 0

New tumour-killer shows great promise in suppressing cancers

Scientists from Nanyang Technological University (NTU) and Lund University, Sweden, have bioengineered a novel molecule which has been proven to successfully kill tumour cells.

Cancer created 3 hours ago | popularity 5 / 5 (1) | comments 0

New factor to control oncogene-induced senescence

An article published on the journal Nature describes the major role that Pyruvate dehydrogenase (PDH) —an enzyme of cellular energy metabolism— plays in the regulation of the cellular senescence induce ...

Cancer created 3 hours ago | popularity not rated yet | comments 0

Anti-CD47 antibody may offer new route to successful cancer vaccination

(Medical Xpress)—Scientists at the School of Medicine have shown that their previously identified therapeutic approach to fight cancer via immune cells called macrophages also prompts the disease-fighting killer T cells ...

Cancer created 5 hours ago | popularity not rated yet | comments 0 | with audio podcast


Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

Estimates reveal low population immunity to new bird flu virus H7N9 in humans

The level of immunity to the recently circulating H7N9 influenza virus in an urban and rural population in Vietnam is very low, according to the first population level study to examine human immunity to the virus, which was ...

Finding a family for a pair of orphan receptors in the brain

Researchers at Emory University have identified a protein that stimulates a pair of "orphan receptors" found in the brain, solving a long-standing biological puzzle and possibly leading to future treatments for neurological ...

Common food supplement fights degenerative brain disorders

Widely available in pharmacies and health stores, phosphatidylserine is a natural food supplement produced from beef, oysters, and soy. Proven to improve cognition and slow memory loss, it's a popular treatment for older ...

Study finds vitamin C can kill drug-resistant TB (w/ video)

In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis (TB) bacteria in laboratory culture. The finding ...

Glaucoma drug can cause droopy eyelids

Prostaglandin analogues (PGAs), drugs which lower intraocular pressure, are often the first line of treatment for people with glaucoma, but their use is not without risks. PGAs have long been associated with blurred vision, ...